Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ofatumumab in Combination With Bortesomib in Patients With Relapsed or Refractory Low-Grade Non-Hodgkins Lymphoma

NCT01119794 is registered in ClinicalTrials.gov with Brown University as lead sponsor.

NCT NCT01119794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01119794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ofatumumab in Combination With Bortesomib in Patients With Relapsed or Refractory Low-Grade Non-Hodgkins Lymphoma
Lead sponsor
Brown University
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2010
Completion date
July 31, 2015
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, non-hodgkins